Last reviewed · How we verify
NCT06914180
Esketamine Combined With PRF for Trigeminal Postherpetic Neuralgia
NA trial testing esketamine group in Postherpetic; Neuralgia, Trigeminal (Etiology) in 174 participants. Not yet recruiting.
1 April 2026
Quick facts
| Lead sponsor | Beijing Tiantan Hospital |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 174 |
| Start date | 1 April 2025 |
| Primary completion | 1 April 2026 |
| Estimated completion | 1 July 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- esketamine group — full drug profile →
- control group — full drug profile →
Conditions studied
- Postherpetic; Neuralgia, Trigeminal (Etiology) — all drugs for Postherpetic; Neuralgia, Trigeminal (Etiology) →
Sponsor
Beijing Tiantan Hospital
Who can join
18 and older, any sex, with Postherpetic; Neuralgia, Trigeminal (Etiology). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial's primary objective is to compare the analgesic efficacy of esketamine in combination with pulsed radiofrequency (PRF) against that of PRF monotherapy in patients with trigeminal postherpetic neuralgia (TPHN).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06914180
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of esketamine group
Trials testing the same drug.
- NCT07050212 — Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation · NA · recruiting
- NCT06896994 — Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia · NA · recruiting
- NCT06914206 — Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated Pain · NA · not yet recruiting
Other Beijing Tiantan Hospital trials
Trials by the same sponsor.
- NCT07341854 — Dexamethasone Palmitate for Postoperative Pain · NA · not yet recruiting
- NCT07527013 — Stratified Blood Pressure Management Strategy After Endovascular Treatment for Acute Ischemic Stroke · Phase 3 · not yet recruiting
- NCT07520370 — Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor · NA · not yet recruiting
- NCT07526987 — Efficacy and Safety of Minocycline in Patients With Acute Ischaemic Stroke Receiving Intravenous Thrombolysis · Phase 3 · not yet recruiting
- NCT07591207 — The Efficacy and Safety of Loxoprofen Sodium Patch in Relieving Postoperative Pain After Laparoscopic Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06914180 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Tiantan Hospital
- Last refreshed: 9 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06914180.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing